New results from the UNITED trial: smallmargin, weekly adaptive MRlinac treatment for glioblastoma significantly cuts normal brain dose (V60Gy ↓ from 146 - 157 → 84 - 93 cm³) and lowers brainstem/optic chiasm dose while maintaining target coverage.
www.sciencedirect.com/science/arti...
sciencedirect.com
Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac: UNITED trial Organs-at-Risk Sparing
To assess the dosimetric impact to organs-at-risk (OARs) and target coverage of a small margin weekly adaptive treatment for glioblastoma delivered on…